We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$585M
AUM Growth
+$56.2M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
830
New
329
Increased
104
Reduced
143
Closed
252
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.9M |
| 2 |
Verizon
VZ
|
+$6.56M |
| 3 |
Lowe's Companies
LOW
|
+$6.21M |
| 4 |
Procter & Gamble
PG
|
+$6.15M |
| 5 |
Danaher
DHR
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 3 |
Apple
AAPL
|
+$11.1M |
| 4 |
UnitedHealth
UNH
|
+$9.36M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$6.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.76% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Healthcare | 14.64% |
| 4 | Consumer Staples | 12.4% |
| 5 | Miscellaneous | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
526
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $210K | 0.04% |
12,800
-11,700
| -48% | -$157K |
|
527
Vanguard Dividend Appreciation ETF
VIG
$113B
| $209K | 0.04% |
+1,675
| New | +$203K |
|
|
ZUO
528
DELISTED
Zuora, Inc.
ZUO
| $205K | 0.04% |
+14,299
| New | +$210K |
|
529
Bank of America
BAC
$428B
| $204K | 0.03% |
+5,800
| New | +$187K |
|
530
Morgan Stanley
MS
$337B
| $204K | 0.03% |
4,000
-12,500
| -76% | -$592K |
|
531
McGrath RentCorp
MGRC
$2.78B
| $202K | 0.03% |
+2,639
| New | +$192K |
|
532
Direxion Daily Small Cap Bear 3x ETF
TZA
$241M
| $202K | 0.03% |
72
-140
| -66% | -$463K |
|
533
Gentex
GNTX
$4.86B
| $201K | 0.03% |
6,946
-19,500
| -74% | -$549K |
|
534
Jones Lang LaSalle
JLL
$17.4B
| $201K | 0.03% |
+1,156
| New | +$182K |
|
535
NetApp
NTAP
$37.4B
| $201K | 0.03% |
+3,227
| New | +$188K |
|
536
Stellantis
STLA
$19.9B
| $201K | 0.03% |
13,679
-27,200
| -67% | -$393K |
|
537
Vanguard Morningstar Value ETF
VTV
$193B
| $201K | 0.03% |
+1,681
| New | +$194K |
|
|
FOLD
538
DELISTED
Amicus Therapeutics
FOLD
| $197K | 0.03% |
20,206
-2,794
| -12% | -$25.6K |
|
|
AVYA
539
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $197K | 0.03% |
+14,614
| New | +$179K |
|
540
Coherus Oncology
CHRS
$226M
| $190K | 0.03% |
+10,536
| New | +$194K |
|
541
Avantor
AVTR
$9.88B
| $189K | 0.03% |
10,400
-9,100
| -47% | -$145K |
|
542
Photronics
PLAB
$1.78B
| $189K | 0.03% |
12,000
+900
| +8% | +$11.3K |
|
|
HAPN
543
Happen Inc
HAPN
$2.13B
| $185K | 0.03% |
+14,620
| New | +$189K |
|
544
e.l.f. Beauty
ELF
$6.26B
| $179K | 0.03% |
+11,123
| New | +$185K |
|
|
CRON
545
Cronos Group
CRON
$1.25B
| $177K | 0.03% |
23,087
+5,587
| +32% | +$42.7K |
|
|
LCI
546
DELISTED
Lannett Company, Inc.
LCI
| $163K | 0.03% |
4,616
-675
| -13% | -$27.4K |
|
|
INN
547
Summit Hotel Properties
INN
$637M
| $160K | 0.03% |
13,000
-9,400
| -42% | -$113K |
|
|
SIEN
548
DELISTED
Sientra, Inc.
SIEN
| $160K | 0.03% |
+1,791
| New | +$135K |
|
549
PG&E
PCG
$39.5B
| $159K | 0.03% |
14,600
-67,845
| -82% | -$581K |
|
550
Ironwood Pharmaceuticals
IRWD
$701M
| $156K | 0.03% |
+11,700
| New | +$129K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Bayesian Capital Management held 830 positions worth $585M, up 11% from $529M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Bayesian Capital Management deployed $17.6M of net new capital in Q4 2019, opening 329 new positions and adding to 104 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $11.3M trimmed.
- Bayesian Capital Management's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 110,200 shares worth $35.5M.
- Bayesian Capital Management added most to Edwards Lifesciences in Q4 2019, an estimated $4.47M increase.
- Bayesian Capital Management's biggest Q4 2019 reduction was Meta Platforms (Facebook), cutting an estimated $11.3M.
- Bayesian Capital Management fully exited Accenture in Q4 2019, selling an estimated $12.8M.
- Bayesian Capital Management's ten largest holdings make up 17% of its $585M portfolio in Q4 2019.
- Bayesian Capital Management opened 329 new positions and closed 252 in Q4 2019.
- Bayesian Capital Management's portfolio value rose 11% quarter-over-quarter to $585M.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.